Literature DB >> 11003259

Effect of combined treatment with perindoprilat and low-power red light laser irradiation on human erythrocyte membrane fluidity, membrane potential and acetylcholinesterase activity.

A Piasecka1, W Leyko, E Krajewska, M Bryszewska.   

Abstract

Erythrocyte membrane fluidity, membrane potential and acetylcholinesterase activity were estimated after in vitro combined treatment of human erythrocytes with perindoprilat and low-power red light irradiation. Membrane fluidity was determined using fluorescent labels spectroscopy; membrane potential was evaluated by means of potential-sensitive fluorescent dyes; and acetylcholinesterase activity was estimated using the Ellman method. Both perindoprilat and laser irradiation, when used separately, increase microviscosity in the polar region and hyperpolarize the membranes in comparison with control erythrocytes. The combined action of these agents does not cause any further change in these parameters. Perindoprilat has an additional inhibitory effect on the activity of acetylcholinesterase, whereas laser irradiation causes an increase in the activity of the enzyme. Their combined action restores the initial activity of the enzyme independently of the sequence of treatment with both agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003259     DOI: 10.1080/003655100750019305

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  2 in total

1.  Effects of low-level laser irradiation on human blood lymphocytes in vitro.

Authors:  Mustafa S Al Musawi; M S Jaafar; B Al-Gailani; Naser M Ahmed; Fatanah M Suhaimi; Nursakinah Suardi
Journal:  Lasers Med Sci       Date:  2017-01-03       Impact factor: 3.161

2.  Influence of MLS laser radiation on erythrocyte membrane fluidity and secondary structure of human serum albumin.

Authors:  Kamila Pasternak; Olga Nowacka; Dominika Wróbel; Ireneusz Pieszyński; Maria Bryszewska; Jolanta Kujawa
Journal:  Mol Cell Biochem       Date:  2013-12-20       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.